Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Top Biochemical and Bioplastics Companies to Lead 7th Biobased Chemicals and Plastics Summit in Bangkok 2018-04-10 10:00
Swift Biosciences Launches Unique Dual Indexing Kits to Improve Multiplexed Next Generation Sequencing 2018-04-06 20:05
MIXiii-BIOMED 2018: Introducing the Best of Israel's Life Science Innovations 2018-04-04 09:00
ProClinical Challenges 'Slow and Stuffy' Search Firms With the Launch of its New Executive Search Brand 2018-03-31 08:00
Uni-Bio Science Group Limited Posts Its 2017 Annual Results 2018-03-30 14:41
AGC Biologics Increases Footprint in Bothell, WA 2018-03-29 23:00
Commencement Of Phase II Clinical Study Of GDC-0084 2018-03-29 08:33
Merck Receives Fast-Track Designation for Tepotinib in Non-Small Cell Lung Cancer in Japan 2018-03-27 21:40
Frost & Sullivan Publishes Update Coverage Report on BiolineRx Ltd.: Continued advancement and execution of BiolineRx's lead oncology project - BL-8040; sufficient funds to support clinical strategy; stock target price remains at NIS 5.15 2018-03-26 23:10
Global Biologics Market to Surpass $300 Billion by 2022 with Accelerated New Launches in Oncology 2018-03-26 22:29
3SBio Unveils 2017 Annual Results: Revenue Soars by 33.5% 2018-03-26 22:09
Frost & Sullivan: Patent Expiries Boost Growth Opportunities for APAC Biosimilars Market 2018-03-26 16:17
Biotech Pioneers, Bruce Rittmann and Mark van Loosdrecht, Win 2018 Stockholm Water Prize 2018-03-22 20:00
Leading US Artificial Intelligence Company Insilico Medicine Establishes Asia's First AI R&D Base in Taiwan 2018-03-22 19:06
Ozurdex(R) (dexamethasone 0.7mg) now available for millions of patients in China with macular edema secondary to retinal vein occlusion 2018-03-22 07:00
AAHRPP Accredits Research Organizations in U.S., Singapore 2018-03-21 19:55
Micell Technologies Announces Expanded Patent Estate 2018-03-20 21:58
Akonni Biosystems Announces Strategic Partnership with Major Chinese Diagnostics Company Righton 2018-03-20 20:00
China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to "Global Cord Blood Corporation" 2018-03-16 20:30
Frost & Sullivan Publishes Update Coverage Report on RedHill Biopharma Ltd.: Net revenues for 2017 met expectations at $4M; likely capital raising in mid-2018 when Phase III results for Crohn's disease are announced; Price target raised to NIS 2.59 2018-03-14 19:48
1 196 197 198 199 200 224